7.17
price down icon2.58%   -0.19
after-market Handel nachbörslich: 7.22 0.05 +0.70%
loading

Organon Co Aktie (OGN) Neueste Nachrichten

pulisher
09:00 AM

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

09:00 AM
pulisher
01:13 AM

Organon Shares Under Pressure Following Critical Analyst Review - Ad-hoc-news.de

01:13 AM
pulisher
Dec 11, 2025

Can Organon’s Steep 2025 Share Price Slide Signal a Long Term Opportunity? - simplywall.st

Dec 11, 2025
pulisher
Dec 11, 2025

Organon pushes bold women’s health agenda at WHX Leaders’ Summit in Accra - MyJoyOnline

Dec 11, 2025
pulisher
Dec 11, 2025

Les billets sont maintenant en vente pour Importance Vitale : sommet national sur la santé des femmes - GlobeNewswire Inc.

Dec 11, 2025
pulisher
Dec 11, 2025

Why Organon (OGN) shares are trading lower today - MSN

Dec 11, 2025
pulisher
Dec 10, 2025

Understanding Momentum Shifts in (OGN) - news.stocktradersdaily.com

Dec 10, 2025
pulisher
Dec 10, 2025

Investors in Organon & Co. (OGN): Protect Your RightsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Dec 10, 2025
pulisher
Dec 10, 2025

WHX Africa Leaders Summit: Organon Unveils Multi-Sector Approach to Women’s Health in Africa - News Ghana

Dec 10, 2025
pulisher
Dec 09, 2025

Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Why Organon (OGN) Shares Are Trading Lower Today - The Globe and Mail

Dec 09, 2025
pulisher
Dec 09, 2025

Organon (OGN) Receives New Coverage with 'Underweight' Rating fr - GuruFocus

Dec 09, 2025
pulisher
Dec 09, 2025

Barclays Initiates Coverage on Organon & Co. (NYSE:OGN) - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Norges Bank Takes $19.78 Million Position in Organon & Co. $OGN - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Organon initiated with an Underweight at Barclays - TipRanks

Dec 08, 2025
pulisher
Dec 08, 2025

American Century Companies Inc. Grows Position in Organon & Co. $OGN - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

What analysts say about Organon Co stockFederal Reserve Announcements & Outstanding Growth Strategies - earlytimes.in

Dec 06, 2025
pulisher
Dec 06, 2025

A Closer Look At Organon & Co.'s (NYSE:OGN) Impressive ROE - 富途牛牛

Dec 06, 2025
pulisher
Dec 04, 2025

Can Organon (OGN) Turn Rising Investor Attention Into a Durable Reboot of Its Core Story? - simplywall.st

Dec 04, 2025
pulisher
Dec 03, 2025

Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada

Dec 03, 2025
pulisher
Dec 03, 2025

Co. (7XP) stock compared to peersPortfolio Update Report & Precise Buy Zone Identification - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Organon & Co. $OGN Shares Acquired by Brandes Investment Partners LP - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Russell Investments Group Ltd. Has $15.96 Million Stock Position in Organon & Co. $OGN - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

Can Organon’s (OGN) Biosimilar Push Transform Its Competitive Position in US Oncology? - Yahoo Finance

Dec 01, 2025
pulisher
Dec 01, 2025

A Look at Organon's Valuation Following FDA Approval of First US Pertuzumab Biosimilar - Yahoo Finance

Dec 01, 2025
pulisher
Dec 01, 2025

Is Organon’s Recent 14% Price Jump Justified After Women’s Health Partnership News? - Yahoo Finance

Dec 01, 2025
pulisher
Dec 01, 2025

What analysts say about Organon Co 7XP stockShort Interest Overview & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Dec 01, 2025
pulisher
Dec 01, 2025

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? - The Globe and Mail

Dec 01, 2025
pulisher
Dec 01, 2025

Grantham Mayo Van Otterloo & Co. LLC Buys 108,429 Shares of Organon & Co. $OGN - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Avoiding Lag: Real-Time Signals in (OGN) Movement - news.stocktradersdaily.com

Nov 29, 2025
pulisher
Nov 29, 2025

Organon (OGN): Exploring Valuation Following FDA Approval of First US Pertuzumab Biosimilar - simplywall.st

Nov 29, 2025
pulisher
Nov 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Nov 29, 2025
pulisher
Nov 29, 2025

Organon & Co. $OGN Shares Sold by Envestnet Asset Management Inc. - MarketBeat

Nov 29, 2025
pulisher
Nov 28, 2025

Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review

Nov 28, 2025
pulisher
Nov 28, 2025

Creative Planning Buys 97,429 Shares of Organon & Co. $OGN - MarketBeat

Nov 28, 2025
pulisher
Nov 28, 2025

Advisors Asset Management Inc. Sells 64,625 Shares of Organon & Co. $OGN - MarketBeat

Nov 28, 2025
pulisher
Nov 27, 2025

Is Organon Co 7XP a good long term investmentLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in

Nov 27, 2025
pulisher
Nov 27, 2025

Organon & Co. $OGN Shares Sold by Geode Capital Management LLC - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks - The Globe and Mail

Nov 26, 2025
pulisher
Nov 25, 2025

EXTENDED CLASS PERIOD: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

Nov 25, 2025
pulisher
Nov 25, 2025

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt

Nov 25, 2025
pulisher
Nov 25, 2025

Congressional Trading Report: Sen. Gary C Peters Sold Over $1K In Organon Stock - Sahm

Nov 25, 2025
pulisher
Nov 25, 2025

Organon (NYSE: OGN) leaders to speak at Piper Sandler 37th Annual Healthcare Conference - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference - Barchart.com

Nov 25, 2025
pulisher
Nov 24, 2025

Organon & Co.Gary C. Peters Congressional Trade on Jul. 10, 2025 - Quiver Quantitative

Nov 24, 2025
pulisher
Nov 24, 2025

Organon’s Deep Discount Comes With a Heavy Dose of Risk - Finimize

Nov 24, 2025
pulisher
Nov 24, 2025

Can OGN’s First US Biosimilar Approval Redefine Its Long-Term Oncology Strategy? - Sahm

Nov 24, 2025
pulisher
Nov 24, 2025

Organon and QC LGU empower women to ‘Take Control’ on World Contraception Day - Inquirer.net

Nov 24, 2025
pulisher
Nov 23, 2025

Organon announces departure of chief commercial officer - MSN

Nov 23, 2025
pulisher
Nov 23, 2025

Kingsview Wealth Management LLC Acquires New Position in Organon & Co. $OGN - MarketBeat

Nov 23, 2025
drug_manufacturers_general SNY
$48.68
price down icon 0.37%
drug_manufacturers_general PFE
$25.85
price up icon 0.19%
$120.40
price down icon 2.28%
$317.74
price up icon 0.11%
drug_manufacturers_general NVO
$50.18
price down icon 0.22%
drug_manufacturers_general MRK
$100.30
price up icon 1.30%
Kapitalisierung:     |  Volumen (24h):